Mechanisms of drug action. pharmacodynamics  What the drug does to the body  This illustrates on the process of which drug alters the body environment,

Slides:



Advertisements
Similar presentations
DRUG-RECEPTOR INTERACTIONS
Advertisements

QUANTITATIVE ASPECTS OF DRUG ACTION
QUANTITATIVE ASPECTS OF DRUG ACTION ilo s By the end of this lecture you will be able to :  Recognize different dose response curves  Classify different.
Nomenclature: Every drug has three names: 1) Chemical Name:  The drug is named according to its chemical structure. 2) Generic name (common name): 
CHAPTER 10 Basic Biopharmaceutics
Drug ? RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb 
Carl B. Goodman, Ph.D. Professor Pharmacology College of Pharmacy & Pharmaceutical Sciences Florida A&M University 308E FSH-SRC
Pharmacology-1 PHL 313 Fourth Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacokinetics Chapter 4.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
ADRENERGIC ANTAGONITS
Drug-Receptor Interactions Pharmacodynamics
Maintaining Water-Salt/Acid-Base Balances and The Effects of Hormones
RESPONSE To alter their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
RESPONSE To alter their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
Principles of Pharmacology: Pharmacodynamics

Principles of Pharmacology: Pharmacodynamics
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Section 1, Lecture 7 Pharmacodynamics
Lecture 6 II. Non-receptor Mechanisms. Direct Physical blocking of channel local anesthetic & amiloride Modulator Bind to the channel protein itself Ca.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Types of antagonists. Antagonists, Overview  Definition “An antagonist is a substance that does not provoke a biological response itself, but blocks.
PHARMACOKINETICS Part 3.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
Active Transport Section 4-2.
Definition: the intestinal, then hepatic degradation or alteration of an ingested medication before it enters the general circulation All blood that.
How drugs Act :General principles Lecture 2
Year One Pharmacodynamics
ISHIK UNIVERSITY FACULTY OF DENTISTRY
© Paradigm Publishing, Inc.1 Chapter 2 Basic Concepts of Pharmacology.
Chemical messengers. intro Chemical messengers include neurotransmitters (very short distance), paracrine agents (short distance) and hormones (long distance)
PHARMACOLOGY INTRODUCTION
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
PHARMACODYNAMICS M.T. Piascik PHA 824 November 11, 2008.
At the end of this lecture, the students will be able to: 1.Define receptors 2.Define agonists 3.List types of agonists 4. Define antagonists 5. List.
Pharmacology PHL 101 Abdelkader Ashour, Ph.D. 10 th Lecture.
Chemical messengers. intro Chemical messengers include neurotransmitters (short distance) and hormones (long distance) Whatever the messenger, the cell.
RESPONSE To alter their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 2 General Pharmacology M212.
Prof. hanan Hagar.  Identify different targets of drug action Ilos Elaborate on drug binding to receptors Differentiate between their patterns of action;
Basic Concepts of Pharmacology © Paradigm Publishing, Inc.
DRUG RECEPTORS AND PHARMACODYNAMICS
QUANTITATIVE ASPECTS OF DRUG ACTION
IN THE NAME OF GOD.
Pharmacodynamics What the drug does to the body?
Adrenergic Antagonists
Pharmacodynamics. * The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced * The.
VASOACTIVE DRUGS February 2017
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Drugs Affecting the Cardiovascular System
Dr. Ahmad Al-Zohyri Dept. of Pharmacology Baghdad College of Medicine
Introduction Pharmacology is the study of the biochemical and physiological aspects of the drug effects including absorption, distribution, metabolism,
Understanding the Basics of Pharmacology
Drug-Receptor Binding and Receptor Types
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
5 Pharmacodynamics.
Pharmacodynamics 20/03/1440 Saja Hamed, Ph.D.
INTRODUCTION to Pharmacology
Pharmacodynamics 2.
Receptors & Drug action at Receptors
Pharmacology UG-Course
Chapter 18a The Endocrine System
Pharmacodynamic Dr. Hashem Mansour.
Introduction to Pharmacology
By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology
Pharmacodynamics i Prof. hanan Hagar.
Introduction to Pharmacology
Chaper 20 Adrenoceptor Antagonists
Presentation transcript:

Mechanisms of drug action

pharmacodynamics  What the drug does to the body  This illustrates on the process of which drug alters the body environment, either by interfering with hormones, receptors, enzymes or other macromolecules

Mechanisms of drug action  Drugs acting on cell membranes  Drugs acting on metabolic processes within the cell  Drugs acting outside the cell

Drugs acting on cell membrane  Acting on receptors on cell membrane –agonists and antagonists  Interference with selective passage of ions across the cell membrane  Inhibition of membrane bound enzymes or pumps

Drugs acting on cell membrane receptors  What is a cell membrane receptor? A macromolacular complex that is embedded in the cell membrane and functions to receive chemical information from the extracellular compartment and to transmit that information to the intracellular compartment.

Receptor down regulation  When a receptor is continuously exposed to an agonist the number of receptors decrease  This is known as receptor down regulation  Ex- nitrates given for angina looses its effect with time

Receptor up regulation  Pronged contact with antagonist results in formation of new receptors  Ex-suddern withdrawal of B blockers lead to worsening of angina /arrythmi  Abrupt withdrawal of the drug lets circulatory NA and A having access to the up regulated receptor number

Antagonists Some drugs bind to cell surface receptors, but do not activate the receptors to trigger a response. When cell surface receptors bind the drug, the endogenous chemical cannot bind to the receptor and cannot trigger a response. The compound is said to “antagonize” or “block” the receptor and is referred to as a receptor antagonist.

example  β 1 receptors are a sub group of adrenoceptors. Endogenous adrenaline and nor adrenaline act on these receptors in heart and increase heart rate and cardiac contractility there by increasing the cardiac work load and the blood pressure.  Propranolol is a β receptor antagonist. It binds to β 1 receptors and block NA and adrenaline binding, there by lowering cardiac contractility and BP

HOW DO DRUGS WORK BY ANTAGONIZING CELL SURFACE RECEPTORS? Cell Membrane Unbound Endogenous Activator (Agonist) of Receptor Inactive Cell Surface Receptor Extracellular Compartment Intracellular Compartment

HOW DO DRUGS WORK BY ANTAGONIZING CELL SURFACE RECEPTORS? Cell Membrane Bound Endogenous Activator (Agonist) of Receptor Active Cell Surface Receptor Extracellular Compartment Intracellular Compartment Cellular Response

HOW DO DRUGS WORK BY ANTAGONIZING CELL SURFACE RECEPTORS? Cell Membrane Displaced Endogenous Activator (Agonist) of Receptor Inactive Cell Surface Receptor Extracellular Compartment Intracellular Compartment Bound Antagonist of Receptor (Drug)

Agonists Some drugs bind to cell surface receptors, and activate the receptors to trigger a response. The compound is said to “agonize ” the receptor and is referred to as a receptor agonist.

Example  The bronchioles have B2 receptors. Adrenaline act on them to cause bronchiodilatation.  In asthma, the bronchioles constrict giving rise to breathing difficulty  The drug used,salbutamol is a B2 receptor agonist that bind B2 receptors and act on them to cause bronchodilatation

Partial agonists  Some drugs,which block the receptors and prevent natural ligands bind can also have a mild stimulating effect on the receptor as well.  So they have both agonist and antagonist actions

Receptor binding  Some drugs bind receptors with weak bonds.(hydrogen bonds,van der Waals bonds etc.)this type of binding would be rapidly reversible and can be displaced by increasing the endogenous substance concentration.  Some drugs bind receptors with strong bonds (covalent bonds)and then the binding would be irriversible

Receptor binding  Irreversible antagonism-The drug phenoxybenzamine is an alpha receptor blocker.  In a condition where there is a tumor of the adrenal gland which releases adrenaline(pheochomocytoma), this drug is given during surgery  The reason is that during surgery, high amounts of adrenaline is released to the circulation

 Adrenaline can bind to alpha receptors to increase the blood pressure  To prevent this a drug that can block the alpha receptors are used  However if a reversible alpha antagonist is used, it can get displaced by high adrenaline levels,and to avoid this an irreversible alpha receptor blocker is used

Physiological antagonism  Drugs might not always act on the same receptor which a physiological substance binds, in order to counteract its action,  Anaphylactic shock is a condition where due to an allergy, mast cells are activated and releases histamine which acts on histamine receptors to cause bronchoconstriction  The drug adrenaline is given as treatment and it acts via a different receptor,the beta 2 adrenoceptor to cause bronchodilatation.

Drugs acting on cell membrane  Acting on receptors on cell membrane –agonists and antagonists  Interference with selective passage of ions across the cell membrane  Inhibition of membrane bound enzymes or pumps

Interference with selective passage of ions across the cell membrane  Calcium channel blockers Calcium is needed for muscle contraction.CCB drugs act on the vascular smooth muscle and block the calcium transport, preventing contraction of vascular smooth muscle. This causes vasodilatation and lowering of blood pressure

Inhibition of membrane bound enzymes or pumps  Cardiac glycosides interfering with the Na+ K+ ATPase pump of the heart muscle which causes Na+ to accumulate within the myocardium.This Na+ is exchanges to Ca2+, so the calcium increases in myocardium increasing contractility of the heart muscle

Drugs acting on metabolic processes with in the cell  Enzyme inhibition  Inhibition of transport process that carry substances across cells  Incorporation of larger molecules  Altering other metabolic processes

Enzyme inhibition  Some important drugs act as enzyme inhibitors  Inhibition caused by drugs may be either reversible or irreversible.  Drug binds to the enzyme by weak bonds in reversible inhibition

Example for competitive enzyme inhibition  Angiotensin II is a very potent chemical that causes rise in BP. Angiotensin II is formed from angiotensin I by the enzyme angiotensin converting enzyme (ACE). ACE inhibitors are medications that slow (inhibit) the activity of the enzyme ACE, which decreases the production of angiotensin II. As a result, the blood vessels dilate, and blood pressure is reduced.

Inhibition of transport process that carry substances across cells  Blocking anion tansport of renal tubule by probenacid can be used to delay excretion of penicillin

Incorporation of larger molecules  Some Anticancer drugs mimic nucleotides and bind the nucleotide chains inhibiting DNA synthesis

Drugs acting outside the cell  Direct chemical interactions Ex- antacids- MgOH is an antacid. In patients with gastritis MgOH when given orally neutralizes the acids in the stomach, with out getting absorbed into cells  Osmosis Ex-magnisium sulphate is a laxative which is given to treat constipation. It is a molacule that is not absorbed into the GIT and remains in the gut.It holds water, so stools become bulky and constipation is relieved

Terminology….

 Affinity—tendency of a drug to combine with a receptor, to produce drug receptor complex and maintain it. There is always affinity constant for specific receptors.   Affinity may vary—it ↑ when the receptor is vacant and ↓ when the receptor is occupied.

Selectivity  Is the ability of the drug to produce the expected action,with out giving rise to unwanted side effects

potency  The amount of drug in relation to its effect Ex- if Xmg of drug A has more effect than the same weight of drug B, drug A is said to be more potent

Lethal dose  A lethal dose (LD) is an indication of the lethality of a given substance. Because resistance varies from one individual to another, the 'lethal dose' represents a dose (usually recorded as dose per kilogram of subject body weight) at which a given percentage of subjects will die.  Animal-based LD measurements are a commonly-used technique in drug research..  LD values for humans are generally estimated by results from testing on animals on human cell cultures

Toxic dose  the dosage that may be expected to cause a toxic effects in majority of the patients to whom it is given.

 ED50 - Median Effective Dose 50; the dose at which 50 percent of the population or sample manifests a given effect; used with quantal dr curves  TD50 - Median Toxic Dose 50 - dose at which 50 percent of the population manifests a given toxic effect  LD50 - Median Toxic Dose 50 - dose which kills 50 percent of the subjects

The ‘therapeutic index’ Therapeutic dose Toxic dose Therapeutic index = Toxic dose Therapeutic dose

Thank you……